Status:
COMPLETED
Tixel Treatment for Dry Eye Symptoms
Lead Sponsor:
Dr Ludger Hanneken
Conditions:
Peri-orbital Wrinkles
Dry Eye
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Dry eye syndrome is caused by a chronic lack of sufficient lubrication and moisture on the surface of the eye. Consequences of dry eyes range from subtle but constant eye irritation to significant inf...
Detailed Description
Tixel® (Novoxel®, Israel) is a thermomechanical system developed for fractional treatment. The system is designed for the treatment of soft tissue by direct conduction of heat, enabling fast water eva...
Eligibility Criteria
Inclusion
- ≥ 18 years
- Mild to Moderate Periorbital wrinkles
- OSDI score of at least 23
- Noninvasive Tear film break up time (NIKBUT) ≤ 10 seconds
- Willing and able to provide written informed consent.
- Willing to participate in all study activities and instructions.
Exclusion
- Pregnancy and breastfeeding
- Lesions in the periorbital area
- Acute severe blepharitis
- Acute conjunctivitis
- Other concomitant anterior eye disease
Key Trial Info
Start Date :
March 28 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 28 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05299619
Start Date
March 28 2019
End Date
March 28 2022
Last Update
March 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vallmedic Vision & Aesthetic
Les Escaldes, Andorra